2025-05-13 - Analysis Report
Okay, here's an analysis of Newmont Corporation (NEM) based on the information you provided. The report is in English, with key numbers presented first, followed by analysis.

**Report: Newmont Corporation (NEM) Analysis**

**1. Performance vs. S&P 500 (VOO)**

*   **NEM Cumulative Return:** 39.92%
*   **VOO Cumulative Return:** 93.97%
*   **Absolute Deviation:** -54.05%
*   **Relative Deviation:** 14.3 (This indicates the current deviation is near the lower end of its historical range compared to VOO).

**Company Overview:** Newmont Corporation is the world's leading gold company and a producer of copper, silver, zinc and lead.

**Alpha, Beta Analysis Table:**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2015-2017  | 34.0%  | 26.5%  | 2.0%   | -0.0  | 33.5   |
| 2016-2018  | 19.0%  | 58.8%  | -2.0%  | 0.0   | 31.4   |
| 2017-2019  | 4.0%   | 58.8%  | -29.0% | -0.1  | 41.0   |
| 2018-2020  | 44.0%  | 58.8%  | 13.0%  | 0.1   | 57.5   |
| 2019-2021  | 83.0%  | 59.9%  | 23.0%  | 0.1   | 61.8   |
| 2020-2022  | -10.0% | 64.1%  | -19.0% | 0.2   | 49.0   |
| 2021-2023  | -37.0% | 71.2%  | -58.0% | 0.5   | 44.7   |
| 2022-2024  | -70.0% | 75.3%  | -91.0% | 0.6   | 41.2   |
| 2023-2025  | -18.0% | 75.3%  | -50.0% | 0.9   | 56.5   |

**Analysis:**

*   NEM has significantly underperformed the S&P 500 over the period considered.
*   The relative deviation suggests that NEM's underperformance, while substantial, is within its historical range compared to the market.
*   The Alpha/Beta analysis shows fluctuating Alpha (outperformance vs. market risk-adjusted) and a Beta generally close to zero, suggesting NEM's price isn't closely correlated with the overall market.  The negative Alphas in recent years are concerning.
*   CAGR(Compound Annual Growth Rate) values has recently decreased.
*   MDD(Maximum Drawdown) has recently increased.

**2. Recent Price Action**

*   **Last Price:** $50.78
*   **Previous Close:** $53.98
*   **Change:** -5.93%
*   **5-day Moving Average:** 53.238
*   **20-day Moving Average:** 53.745
*   **60-day Moving Average:** 48.6527

**Analysis:**

*   The stock experienced a significant drop (-5.93%) compared to the previous close, indicating potential negative sentiment or news impact.
*   The price is below both the 5-day and 20-day moving averages, suggesting a short-term downtrend. The 60-day moving average below its price indicated that the stock price has recently decreased.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3676 (Low Risk)
*   **RSI:** 39.35 (Approaching oversold territory)
*   **PPO:** -0.8853 (Negative, indicating a downtrend)
*   **20-day Relative Deviation Change:** -4.8 (Short-term decline in relative performance)
*   **Expected Return:** -90.8% (Significant underperformance vs. S&P 500 over the long term)

**Analysis:**

*   The MRI suggests relatively low market risk, but this is a general market indicator and doesn't specifically address NEM's risk.
*   The RSI value suggests the stock may be approaching oversold conditions, which could lead to a potential bounce.
*   The negative PPO reinforces the downtrend indicated by the moving averages.
*   The large negative Expected Return is a significant concern, suggesting analysts anticipate continued underperformance relative to the S&P 500.
*   The significant price change warrants further investigation into specific news or events that might have triggered it.

**4. Recent News & Significant Events**

*   **2025-05-09:** Major business developments, regulatory changes, or market events affecting NEM.
*   **2025-05-13:** Analyst discussions on NEM's performance in the context of industry and global economic factors.
*   **2025-05-10:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-05-11:** Expert advice to monitor news and company announcements.

**Analysis:**

*   The news snippets indicate recent volatility and potential uncertainty surrounding NEM. Further research into these news sources is crucial to understand the underlying causes.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-04-24 | 1.68 | $5.01B     |
| 2024-10-24 | 0.8  | $4.61B     |
| 2024-07-25 | 0.74 | $4.40B     |
| 2024-04-29 | 0.15 | $4.02B     |
| 2025-04-24 | 0.15 | $4.02B     |

**Analysis:**

*   The earnings data presents a mixed picture. While recent EPS and revenue figures show improvement compared to earlier periods, the duplication of the 2025-04-24 entry with different EPS and Revenue values suggests a data error that needs clarification.

**6. Financial Information**

Revenue and Profitability:

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $5.01B   | 46.13%        |
| 2024-12-31 | $5.65B   | 45.51%        |
| 2024-09-30 | $4.61B   | 36.13%        |
| 2024-06-30 | $4.40B   | 37.35%        |
| 2024-03-31 | $4.02B   | 31.39%        |

Capital and Profitability:

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-03-31 | $31.25B  | 6.05%   |
| 2024-12-31 | $29.93B  | 4.69%   |
| 2024-09-30 | $29.71B  | 3.10%   |
| 2024-06-30 | $29.38B  | 2.90%   |
| 2024-03-31 | $28.89B  | 0.59%   |

**Analysis:**

*   Revenue and profit margins have generally increased over the past five quarters.
*   Equity has also been growing, and the Return on Equity (ROE) has improved significantly, indicating better profitability on shareholder investments.

**7. Overall Analysis**

Newmont Corporation (NEM) is currently facing significant challenges.  While the company's revenue, profit margins, equity, and ROE have shown positive trends, its stock is underperforming the S&P 500, with a substantial negative expected return. Recent price action has been negative, with the stock trading below its short-term moving averages. Technical indicators suggest the stock may be approaching oversold territory, but the negative PPO and recent decline in relative performance are concerning.

The recent news snippets point to potential volatility and uncertainty.  A deeper dive into these news sources is critical. The earnings data requires clarification due to potential errors.

**In summary, while Newmont's financial performance shows signs of improvement, the stock's underperformance and negative outlook warrant caution. Investors should conduct thorough due diligence, considering the company's financial health, industry trends, and recent news events before making any investment decisions.**
